Prevalence and clinical predictors of silent myocardial ischemia in asymptomatic type 2 Diabetes Mellitus patients at Puducherry, India

K. Shaik Anwar Hussain


Background: Silent MI is common among diabetics due to autonomic dysfunction and loss of pain alert mechanism. There are various risk factors associated with silent MI in diabetes which needs screening earlier to prevent unanticipated cardiovascular mortality. The objective of the present investigation was to study the prevalence and clinical factors associated with silent myocardial ischemia as diagnosed by TMT among type 2 diabetics who had no previous history or symptoms of cardio-vascular disease.

Methods: A total of 200 type 2 diabetes affected subjects with duration of diabetes for at least 6 months, above 18 years of age, attending to the diabetology OPD, during the time period June 2017 to May 2018 were included in the study. Blood investigations and TMT were done for all the participants and documented in a proforma.

Results: Silent MI was documented by using TMT in 36.5% (n=73) of patients with type 2 diabetes mellitus. The factors like age (59.1±16.3 years), duration of diabetes (8.2±2.6 years), obesity (BMI=29.6±4.7 kg/m2), Glycated haemoglobin (9.7±2.8 %), lipid levels and post-prandial blood sugar levels (236±11.8 mg/dl) associated well with silent MI as predicted by TMT. Fasting blood sugar did not show significant association with Silent MI.

Conclusions: The prevalence of silent MI was higher among the type 2 diabetic individuals compared to non-diabetics. Age, duration of diabetes, HbA1c levels, BMI, dyslipidemia and post prandial blood glucose levels were associated significantly with incidence of silent MI in patients with type 2 diabetes.


Type 2 diabetes mellitus, Tread mill test, Silent Myocardial ischemia

Full Text:



Bonow RO, Bohannon N, Hazzard W. Risk stratification in coronary artery disease and special populations. Am J Med. 1996;101:4A17s-4A22s.

Alexander CM, Landsman PB, Teutsch SM. Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am J Cardiol. 2000; 86:897-902.

Chico A, Tomas A, Novials A. Silent myocardial ischemia is associated with autonomic neuropathy and other cardiovascular risk factors in type 1 and type 2 diabetic subjects, especially in those with microalbuminuria. Endocrine. 2005; 27:213-17.

American Diabetes Association-Clinical Practice Recommendations Diabetes care 2007; 30(Suppl.4).

Swaminathan DK, Gayathri DM. “Study of treadmill test in detecting asymptomatic coronary artery disease in type 2 diabetes mellitus.” IOSR J Dental Medi Sci. 2016;15(08):1-6.

DeLuca AJ, Saulle LN, Aronow WS, Ravipathi G, Weis MB. Association of hemoglobin A1c with prevalence of silent myocardial ischaemia. Am J Cardiol. 2005; 95(12): 1472-74.

Ravipati G, Aronow WS, Ahn C, Sujata K, Saulle LN, Weiss MB. Association of hemoglobin A1c level with the severity of coronary artery disease in patients with diabetes mellitus. Am J Cardiol. 2006;97(7):968-9.

Sukhija R, Chanwal D, Gambhir DS, Dewan R. Silent myocardial ischaemia in patients with type II diabetes mellitus and its relation with autonomic dysfunction. Indian Heart J. 2000;52(5):540-6.

Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Eng J Med. 2000;343(20):1445-53.

Klein C, Nekolla SG, Bengel FM, Momose M, Sammer A, Haas F, rt al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation. 2002;105(2):162-7.

Wagner A, Mahrholdt H, Sechtem U, Kim RJ, Judd RM. MR imaging of myocardial perfusion and viability. Mag Reson Imaging Clin. 2003;11(1):49-66.